Howard Hughes Medical Institute’s Target TGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-98
Closed -$9.58K 431
2025
Q4
$9.58K Hold
98
0.01% 219
2025
Q3
$8.79K Sell
98
-1
-1% -$98 0.01% 236
2025
Q2
$9.77K Buy
+99
New +$9.51K ﹤0.01% 207

Other funds holding TGT

Howard Hughes Medical Institute's TGT Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Target (TGT) in Q1 2026, closing a stake of 98 shares — an estimated $9.58K sold.

Howard Hughes Medical Institute first reported a position in TGT in Q2 2025 and held it in 3 quarters. The position peaked at $9.77K in Q2 2025. 1,847 funds tracked by Wall St. Rank hold TGT as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Target position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 98 Target shares in Q1 2026, an estimated $9.58K.
  • Howard Hughes Medical Institute first reported a position in Target in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Target position peaked at $9.77K in Q2 2025.
  • 1,847 funds tracked by Wall St. Rank held Target as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.